For the fiscal year ending March 2026, consolidated sales reached \u00a5416.5 billion (up 2.3% YoY), net income was \u00a527.8 billion (up 11.4%), setting a record high. Segment-wise, Chemical Products, Food, and Life Sciences achieved revenue and profit growth. The outlook for the next period forecasts sales of \u00a5453.0 billion and net income of \u00a528.8 billion.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4401","jir_company_name":"Adeka Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4401-20260514-01.pdf","jir_short_summary":"For the fiscal year ending March 2026, consolidated sales reached \u00a5416.5 billion (up 2.3% YoY), net income was \u00a527.8 billion (up 11.4%), setting a record high. Segment-wise, Chemical Products, Food, and Life Sciences achieved revenue and profit growth. The outlook for the next period forecasts sales of \u00a5453.0 billion and net income of \u00a528.8 billion.","jir_summary":"### Performance Overview\nFor the fiscal year ending March 2026, consolidated sales reached \u00a5416.5 billion (up 2.3% YoY), with net income of \u00a527.8 billion (up 11.4%), marking a record high. Segments including Chemical Products, Food, and Life Sciences saw revenue and profit increases, with Life Sciences performing particularly well due to expanded sales overseas. The forecast for the next period anticipates sales of \u00a5453.0 billion and net income of \u00a528.8 billion, indicating continued growth.\n\n### Shareholder Impact and Future Outlook\nThe company maintains a stable dividend, targeting a payout ratio of over 40%, with an expected dividend of \u00a560 per share for the fiscal year ending March 2026. The next period also plans to increase dividends. Despite an uncertain business environment, investments will continue in growth fields such as semiconductors and pharmaceuticals to achieve long-term growth.","jir_financial_highlights":"Sales Revenue: \u00a5416.5 billion (YoY +2.3%)\nNet Income Attributable to Owners of Parent: \u00a527.8 billion (YoY +11.4%)\nConsolidated Total Assets: 559,987 million yen (YoY +3.1%)","jir_category":"","jir_hashtags":"#Adeka, #IRFinancialResults, #JapaneseStocks","jir_key_figures":"Sales Revenue: \u00a5416.5 billion (up 2.3% YoY)\nNet Income Attributable to Owners of Parent: \u00a527.8 billion (up 11.4% YoY)\nConsolidated Total Assets: \u00a5559,987 million (up 3.1% YoY)","jir_meta_title":"[Adeka] Financial Results for 2026 | Sales of \u00a5416.5 billion, Net Income of \u00a527.8 billion","jir_meta_description":"Overview of Adeka Co., Ltd.'s financial results for the fiscal year ending March 2026. Sales of \u00a5416.5 billion, net income of \u00a527.8 billion set a record high. Positive outlook for the next period.","jir_og_title":"[Adeka] Financial Results for 2026 | Sales of \u00a5416.5 billion, Net Income of \u00a527.8 billion","jir_og_description":"Summary of Adeka's 2026 financial results. Achieved record-high sales of \u00a5416.5 billion and net income of \u00a527.8 billion. Continued growth anticipated.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7996,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-49813","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n